Homology Medicines (FIXX) PT Lowered to $3 at RBC Capital
Tweet
Share
E-mailGet Alerts FIXX Hot Sheet
Price: $1.44 -4%
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 24 | New: 19
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 24 | New: 19
Join SI Premium – FREE
RBC Capital analyst Luca Issi lowered the price target on Homology Medicines (NASDAQ: FIXX) to $3.00 (from $4.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- R5 Capital Downgrades Kroger (KR) to Sell, 'particularly vulnerable'
- JPMorgan Downgrades Seven Group Holdings Limited (SVW:AU) (SVNWF) to Neutral
- CSR Ltd. (CSR:AU) (CSRLF) PT Raised to AUD5.60 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
